Overcoming the challenges of implementing serialisation across a diverse pharmaceutical manufacturing environment: part one

Published: 7-Feb-2017

The US and European healthcare industry is changing rapidly. Organisations are being challenged to adapt to new legislation, lower costs and increase efficiency, all while improving patient safety, ensuring supply chain security, minimising revenue loss and standardising across multiple facilities

You need to be a subscriber to read this article.
Click here to find out more.

The upcoming industry requirement for drug serialisation in the US and Europe cannot be ignored.

It is not a case of “if” or “when” but a case of how best to implement new systems and processes in time for the looming deadlines.

Carlos Machado, Serialisation Director at Zenith Technologies, explores the challenges, drivers and benefits around serialisation and discusses how to comply with the new regulations on-time, on-budget and with flawless execution.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like